Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Predictive Oncology Inc. - Common Stock (NQ:POAI)

1.160 UNCHANGED
Streaming Delayed Price Updated: 9:30 AM EDT, Mar 18, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,575
Open 1.160
Bid (Size) 1.140 (1)
Ask (Size) 1.180 (11)
Prev. Close 1.160
Today's Range 1.160 - 1.160
52wk Range 0.5500 - 3.060
Shares Outstanding 4,063,081
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Renovaro Completes First Milestone Payment to Finalize Definitive Agreement with Predictive Oncology
From Renovaro Inc
Via GlobeNewswire
Predictive Oncology Moves to Finalize Definitive Merger Agreement With Renovaro Biosciences
From Predictive Oncology Inc.
Via GlobeNewswire

Performance

YTD
+26.1%
+26.1%
1 Month
-40.5%
-40.5%
3 Month
+54.7%
+54.7%
6 Month
+28.9%
+28.9%
1 Year
-57.0%
-57.0%

More News

Read More
Predictive Oncology Closes Registered Direct Offering
From Predictive Oncology Inc.
Via GlobeNewswire
Predictive Oncology Announces Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
From Predictive Oncology Inc.
Via GlobeNewswire
(POAI) - Analyzing Predictive Oncology's Short Interest
Via Benzinga
What's Going On With Predictive Oncology Shares Tuesday?
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Predictive Oncology Reports Positive Results Utilizing Artificial Intelligence for Drug Repurposing
From Predictive Oncology Inc.
Via GlobeNewswire
Predictive Oncology Partners with Switzerland-Based Tecan Group Ltd. to Expand High-Throughput Drug Screening to Include Human Tumor Spheroids Using Automated Imaging and 3D Analysis
From Predictive Oncology Inc.
Via GlobeNewswire
Predictive Oncology Announces Planned European Launch of its ChemoFx® Treatment Selection Marker and Tumor Profiling Assay
From Predictive Oncology Inc.
Via GlobeNewswire
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates LBRDA, NARI, ML, POAI on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
PREDICTIVE ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Predictive Oncology Inc. - POAI
From Kahn Swick & Foti, LLC
Via Business Wire
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates RHE, FUBO, POAI on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
Renovaro Issues Shareholder Letter and Provides Corporate Update
From Renovaro Inc
Via GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Predictive Oncology Inc. (Nasdaq - POAI), SunLink Health Systems, Inc. (NYSE American - SSY), Universal Stainless & Alloy Products, Inc. (Nasdaq - USAP), Patterson
From Brodsky & Smith LLC
Via GlobeNewswire
POAI Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Predictive Oncology Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
Renovaro to Acquire Predictive Oncology in All-Stock Transaction
From Renovaro Inc
Via GlobeNewswire
Predictive Oncology Announces Agreement to be Acquired by Renovaro
From Predictive Oncology Inc.
Via GlobeNewswire
Predictive Oncology Announces Progress in Ongoing Evaluation of Strategic Alternatives
From Predictive Oncology Inc.
Via GlobeNewswire
This SolarEdge Technologies Analyst Turns Bearish; Here Are Top 5 Downgrades For Friday
Via Benzinga
Predictive Oncology Reports Third Quarter 2024 Financial Results and Provides Strategic Update
From Predictive Oncology Inc.
Via GlobeNewswire
InvestorNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Announces Participation at the H.C. Wainwright 26th Annual Global Investment Conference
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
Predictive Oncology to Present at the H.C. Wainwright 26th Annual Global Investment Conference
From Predictive Oncology Inc.
Via GlobeNewswire
TinyGemsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Reports on Study Confirming Long-Term Stability, Viability of Proprietary Tumor Specimen Biobank
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
Predictive Oncology Study Demonstrates Long-Term Stability and Viability of Proprietary Biobank of Primary Tumor Specimens for Pharmaceutical Drug Discovery
From Predictive Oncology Inc.
Via GlobeNewswire
InvestorNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Announces Q2 2024 Financial Results, Provides Business Update
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence

Frequently Asked Questions

Is Predictive Oncology Inc. - Common Stock publicly traded?
Yes, Predictive Oncology Inc. - Common Stock is publicly traded.
What exchange does Predictive Oncology Inc. - Common Stock trade on?
Predictive Oncology Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Predictive Oncology Inc. - Common Stock?
The ticker symbol for Predictive Oncology Inc. - Common Stock is POAI on the Nasdaq Stock Market
What is the current price of Predictive Oncology Inc. - Common Stock?
The current price of Predictive Oncology Inc. - Common Stock is 1.160
When was Predictive Oncology Inc. - Common Stock last traded?
The last trade of Predictive Oncology Inc. - Common Stock was at 03/18/25 09:30 AM ET
What is the market capitalization of Predictive Oncology Inc. - Common Stock?
The market capitalization of Predictive Oncology Inc. - Common Stock is 4.71M
How many shares of Predictive Oncology Inc. - Common Stock are outstanding?
Predictive Oncology Inc. - Common Stock has 5M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.